The Celiac, IBS, and Crohn’s Array (CICA) evaluates your genetic risk for celiac disease and checks for genetic markers associated with Crohn’s disease.
The CICA is designed to provide an accurate evaluation of GI tract function by gathering information from various pathways.
This can be combined with the Alcat Test to evaluate innate immune cell responses to as many as 250 other foods (including gluten, gliadin, casein and whey) and substances for the most comprehensive assessment.
The Alcat Test measures personalized nutrition at the cellular level. The core technology is a blood test that measures the body’s cellular response to challenges from a wide array of substances including various foods, additives, colorings and chemicals. The individual’s cellular reactivity after exposure of the blood to the various test agents, versus the person’s own baseline control, tells you which substances may be causing a sensitivity-related response in the body.
The Alcat Test has been validated by demonstrating a high correlation with double-blind oral challenges with both foods and food additives.10 In addition, a controlled study from Baylor Medical College reported 98% success for weight loss and/or improvement in body composition from patients that followed the recommended eating plan based on the Alcat test.
Conditions associated with food and chemical sensitivity
The Alcat Test is a food screening test, it does not diagnose a disease, but may help many chronic conditions associated or influenced by food, such as:
Digestive disorders, e.g. bloating, constipation, Irritable Bowel Syndrome
- Metabolic disorders, weight management, obesity, Type II Diabetes
- Inflammatory conditions that effect skin, joints or respiratory system
- General inflammatory conditions involving overactive immune function
*Please see individual product pages for testing food/item lists
**Nutritional services available for tests of 150 foods or more
Genetic CICA Test
More than 95% of patients with celiac disease possess HLA-DQ2.5 and/or HLA-DQ8 genotype. More than 90% of those with celiac have the DQ2.5 genotype. Absent these markers, development of celiac is highly unlikely.
Crohn’s disease is triggered by a variety of environmental and genetic factors. It is described as a chronic inflammatory bowel disease (IBD) caused by a dysregulation of the immune response to intestinal flora and in parallel, accompanied by a defect of the epithelial barrier.
The predominant genetic markers are:
- NOD2/CARD15 associated with the innate immune system and the activation of nuclear factor кB (NF- кB).
- T300A mutation in the ATG16L1 gene increases its susceptibility to degradation by Caspase 3 and thus is associated with autophagy.